Home

asdasd22d
Title: Slide 2
Title Credit Type Therapeutic Area Format
Venous Stenting in Non-Thrombotic Venous Patients AANP, ARRT, CME, CNE Radiology, Vascular On-Demand Webcast
The Role of Novel Targeted Therapies in the Treatment of R/R ALL: Focus on Immunotherapies AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
Checking In on CLL/SLL Treatments: New Data, New Discoveries AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
A Fresh Look at MZL and Waldenström Macroglobulinemia: Management Approaches AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
PI3K Inhibitors in the Treatment of Non-Hodgkin Lymphomas AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
Clinical Updates in Mantle Cell Lymphoma: Emerging Therapies and Evolving Treatment Strategies AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
PI3K and EZH2 Inhibitors in the Treatment of Non-Hodgkin Lymphomas AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
COVID-19 Update: Adapting Management Strategies and Vaccine Recommendations AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
Novel Therapeutic Targets in Advanced Classic Hodgkin Lymphoma: Present and Future Challenges AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
TKIs in the Treatment of Ph+ CML: Achieving Optimal Outcomes AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
Advances in the Treatment of ALL in Adults: Treatment Approaches for Ph Positivity AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast
Advances in R/R Multiple Myeloma: Overcoming Treatment Resistance with Novel Targets AANP, CME, CNE, CPE Hematology, Oncology On-Demand Webcast

Pages